Interpace Biosciences Inc (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,356 | -16,073 | -4,565 | -25,527 | -11,914 |
| Depreciation Amortization | 20,696 | 2,391 | 1,425 | 2,034 | 3,046 |
| Income taxes - deferred | -1,167 | -5,035 | N/A | N/A | N/A |
| Accounts receivable | -5,486 | -3,422 | 8,256 | -1,054 | 1,397 |
| Accounts payable and accrued liabilities | 1,019 | 786 | -1,038 | -751 | 873 |
| Other Working Capital | -6,531 | -4,058 | -2,246 | -12,328 | 3,387 |
| Other Operating Activity | -17,017 | 9,033 | -5,344 | 27,340 | 5,196 |
| Operating Cash Flow | $-19,842 | $-16,378 | $-3,512 | $-10,286 | $1,985 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -353 | -2,851 | -1,818 | -1,112 | -343 |
| Net Acquisitions | N/A | -13,359 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -1,500 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -8,500 | N/A | N/A | N/A |
| Other Investing Activity | 26,751 | -9,155 | 0 | 0 | 0 |
| Investing Cash Flow | $26,398 | $-25,365 | $-3,318 | $-1,112 | $-343 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 451 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -21,808 | 19,215 | -314 | -156 | -16 |
| Financing Cash Flow | $-21,357 | $19,215 | $-314 | $-156 | $-16 |
| Beginning Cash Position | 23,111 | 45,639 | 52,783 | 64,337 | 62,711 |
| End Cash Position | 8,310 | 23,111 | 45,639 | 52,783 | 64,337 |
| Net Cash Flow | $-14,801 | $-22,528 | $-7,144 | $-11,554 | $1,626 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,842 | -16,378 | -3,512 | -10,286 | 1,985 |
| Capital Expenditure | -353 | -2,851 | -1,818 | -1,112 | -343 |
| Free Cash Flow | -20,195 | -19,229 | -5,330 | -11,398 | 1,642 |